Enzo Biochem Inc (NYSE:ENZ)

6.48
Delayed Data
As of May 18
 -0.30 / -4.42%
Today’s Change
5.35
Today|||52-Week Range
12.04
-20.49%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$302.7M

Company Description

Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY.

Contact Information

Enzo Biochem, Inc.
60 Executive Boulevard
New York New York 11735
P:(212) 583-0100
Investor Relations:

Employees

Shareholders

Other institutional40.66%
Mutual fund holders29.26%
Individual stakeholders13.36%

Top Executives

Elazar RabbaniChairman, Chief Executive Officer & Secretary
Barry W. WeinerPresident, CFO, Treasurer & Director
James M. O'BrienSenior Vice President-Finance
Kara CannonHead-Global Sales & Marketing
Paul C. O'BrienVice President-Global Human Resources